99 related articles for article (PubMed ID: 14974156)
1. [Effect of learning about the human genome on the development of pathology].
Szentirmay Z
Orv Hetil; 2003 Dec; 144(51):2499-508. PubMed ID: 14974156
[TBL] [Abstract][Full Text] [Related]
2. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
3. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
Zhang DL; Ji L; Li YD
Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphism in transcriptional regulatory regions and expression of environmentally responsive genes.
Wang X; Tomso DJ; Liu X; Bell DA
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):84-90. PubMed ID: 16002116
[TBL] [Abstract][Full Text] [Related]
5. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
[TBL] [Abstract][Full Text] [Related]
6. [The Human Genome Project, genetic viability and genetic epidemiology].
Hagymási K; Tulassay Z
Orv Hetil; 2005 Dec; 146(51):2575-80. PubMed ID: 16468611
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
8. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
[TBL] [Abstract][Full Text] [Related]
9. Human genetic polymorphisms.
Conneally PM
Dev Biol Stand; 1994; 83():107-10. PubMed ID: 7883083
[TBL] [Abstract][Full Text] [Related]
10. Health-related disparities: influence of environmental factors.
Olden K; White SL
Med Clin North Am; 2005 Jul; 89(4):721-38. PubMed ID: 15925646
[TBL] [Abstract][Full Text] [Related]
11. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
[TBL] [Abstract][Full Text] [Related]
12. [Present and future prospects of individualized medical services by genetic tests].
Kawabata I; Itoh Y
Rinsho Byori; 2002 Dec; 50(12):1124-9. PubMed ID: 12652679
[TBL] [Abstract][Full Text] [Related]
13. Structural variants: changing the landscape of chromosomes and design of disease studies.
Feuk L; Marshall CR; Wintle RF; Scherer SW
Hum Mol Genet; 2006 Apr; 15 Spec No 1():R57-66. PubMed ID: 16651370
[TBL] [Abstract][Full Text] [Related]
14. Systematic analysis of genetic alterations in tumors using Cancer Genome WorkBench (CGWB).
Zhang J; Finney RP; Rowe W; Edmonson M; Yang SH; Dracheva T; Jen J; Struewing JP; Buetow KH
Genome Res; 2007 Jul; 17(7):1111-7. PubMed ID: 17525135
[TBL] [Abstract][Full Text] [Related]
15. [Biological bases for individualising prescriptions in oncology: the germline genome].
Robert J; Le Morvan V
Bull Cancer; 2008 Oct; 95(10):911-21. PubMed ID: 19004720
[TBL] [Abstract][Full Text] [Related]
16. Clinical genotyping: the need for interrogation of single nucleotide polymorphisms and mutations in the clinical laboratory.
Tsongalis GJ; Coleman WB
Clin Chim Acta; 2006 Jan; 363(1-2):127-37. PubMed ID: 16102741
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus.
Smeets SJ; Braakhuis BJ; Abbas S; Snijders PJ; Ylstra B; van de Wiel MA; Meijer GA; Leemans CR; Brakenhoff RH
Oncogene; 2006 Apr; 25(17):2558-64. PubMed ID: 16314836
[TBL] [Abstract][Full Text] [Related]
18. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
Zhang J; Jin X; Fang S; Wang R; Li Y; Wang N; Guo W; Wang Y; Wen D; Wei L; Dong Z; Kuang G
Carcinogenesis; 2005 Oct; 26(10):1748-53. PubMed ID: 15930031
[TBL] [Abstract][Full Text] [Related]
19. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
[TBL] [Abstract][Full Text] [Related]
20. Large fragment Bst DNA polymerase for whole genome amplification of DNA from formalin-fixed paraffin-embedded tissues.
Aviel-Ronen S; Qi Zhu C; Coe BP; Liu N; Watson SK; Lam WL; Tsao MS
BMC Genomics; 2006 Dec; 7():312. PubMed ID: 17156491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
